Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SEMA3A partially reverses VEGF effects through binding to neuropilin-1.
Palodetto B, da Silva Santos Duarte A, Rodrigues Lopes M, Adolfo Corrocher F, Roversi FM, Soares Niemann F, Priscila Vieira Ferro K, Leda Figueiredo Longhini A, Melo Campos P, Favaro P, Teresinha Olalla Saad S. Palodetto B, et al. Among authors: roversi fm. Stem Cell Res. 2017 Jul;22:70-78. doi: 10.1016/j.scr.2017.05.012. Epub 2017 Jun 3. Stem Cell Res. 2017. PMID: 28636974 Free article.
Serine protease inhibitor kunitz-type 2 is downregulated in myelodysplastic syndromes and modulates cell-cell adhesion.
Roversi FM, Lopes MR, Machado-Neto JA, Longhini AL, Duarte Ada S, Baratti MO, Palodetto B, Corrocher FA, Pericole FV, Campos Pde M, Favaro P, Traina F, Saad ST. Roversi FM, et al. Stem Cells Dev. 2014 May 15;23(10):1109-20. doi: 10.1089/scd.2013.0441. Epub 2014 Feb 18. Stem Cells Dev. 2014. PMID: 24410667 Free PMC article. Clinical Trial.
Hematopoietic cell kinase (HCK) is a potential therapeutic target for dysplastic and leukemic cells due to integration of erythropoietin/PI3K pathway and regulation of erythropoiesis: HCK in erythropoietin/PI3K pathway.
Roversi FM, Pericole FV, Machado-Neto JA, da Silva Santos Duarte A, Longhini AL, Corrocher FA, Palodetto B, Ferro KP, Rosa RG, Baratti MO, Verjovski-Almeida S, Traina F, Molinari A, Botta M, Saad ST. Roversi FM, et al. Biochim Biophys Acta Mol Basis Dis. 2017 Feb;1863(2):450-461. doi: 10.1016/j.bbadis.2016.11.013. Epub 2016 Nov 11. Biochim Biophys Acta Mol Basis Dis. 2017. PMID: 27840303 Free article.
Up-regulation of SPINT2/HAI-2 by Azacytidine in bone marrow mesenchymal stromal cells affects leukemic stem cell survival and adhesion.
Roversi FM, Cury NM, Lopes MR, Ferro KP, Machado-Neto JA, Alvarez MC, Dos Santos GP, Giardini Rosa R, Longhini AL, Duarte ADSS, Pericole FV, Favaro P, Yunes JA, Saad STO. Roversi FM, et al. J Cell Mol Med. 2019 Feb;23(2):1562-1571. doi: 10.1111/jcmm.14066. Epub 2018 Nov 28. J Cell Mol Med. 2019. PMID: 30484958 Free PMC article.
The antitumor effects of WNT5A against hematological malignancies.
Bueno MLP, Saad STO, Roversi FM. Bueno MLP, et al. Among authors: roversi fm. J Cell Commun Signal. 2023 Dec;17(4):1487-1499. doi: 10.1007/s12079-023-00773-8. Epub 2023 Jun 13. J Cell Commun Signal. 2023. PMID: 37310653 Free PMC article.
Comprehensive analysis of the HCK gene in myeloid neoplasms: Insights into biological functions, prognosis, and response to antineoplastic agents.
Carvalho MFL, de Almeida BO, Bueno MLP, Vicari HP, Lima K, Rego EM, Roversi FM, Machado-Neto JA. Carvalho MFL, et al. Among authors: roversi fm. Hematol Transfus Cell Ther. 2023 Dec 31:S2531-1379(23)02607-X. doi: 10.1016/j.htct.2023.11.007. Online ahead of print. Hematol Transfus Cell Ther. 2023. PMID: 38326180 Free article.
WNT5A in tumor development and progression: A comprehensive review.
Bueno MLP, Saad STO, Roversi FM. Bueno MLP, et al. Among authors: roversi fm. Biomed Pharmacother. 2022 Nov;155:113599. doi: 10.1016/j.biopha.2022.113599. Epub 2022 Sep 9. Biomed Pharmacother. 2022. PMID: 36089446 Free article. Review.
18 results